Retracted: Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly
Saved in:
Main Author: | Emergency Medicine International |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Emergency Medicine International |
Online Access: | http://dx.doi.org/10.1155/2024/9837328 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome
by: Elif Tugba Tuncel, et al.
Published: (2025-01-01) -
Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study
by: S. S. Kardasheva, et al.
Published: (2018-11-01) -
Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis
by: E. A. Trush, et al.
Published: (2024-08-01) -
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents
by: Yvonne Tse, et al.
Published: (2017-01-01) -
Efficacy Comparison of Nitazoxanide Combined with Lactulose versus Lactulose Monotherapy in Managing Overt Hepatic Encephalopathy
by: Taimoor Hafeez Janjua, et al.
Published: (2025-01-01)